Here is What Analysts Have to Say About Hinge Health (HNGE)

Hinge Health (NYSE:HNGE) is one of the most promising mid-cap healthcare stocks under $50.

On December 19, the consensus ratings indicate a strong bullish stance towards Hinge Health (NYSE:HNGE). All 12 analysts covering the stock have assigned Buy ratings, which reflect favorably upon its prospects. The resulting consensus 1-year average price target for the stock is $67.53, which offers a lucrative 42.9% upside from the current level.

On December 12, Citizens reiterated its bullish stance on Hinge Health (NYSE:HNGE). The firm assigned a Buy rating to the stock, with a target price of $65 a share. This estimate offered a 38% upside to investors from the prevailing levels.

The firm’s positive sentiment is driven by Hinge Health’s (NYSE:HNGE) strong competitive position in the market. It is based on their strong ties with the top 5 national health plans and also the three most prominent pharmacy benefit managers (PBMs) across the U.S.

According to Citizens, Hinge Health’s (NYSE:HNGE) already established links within the healthcare landscape will prove to be the key enablers for future growth opportunities within this space. Being a leading player within the digital musculoskeletal (MSK) market, the company still has immense potential to grow.

Hinge Health (NYSE:HNGE) leverages an AI-enabled care model to automate the delivery of healthcare services. The company delivers customized, drug-free pain relief to users through health plans devised by physical therapists. They address musculoskeletal conditions of patients through an FDA-approved wearable device that is user-friendly and cost-efficient.

While we acknowledge the potential of HNGE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT:  Cathie Wood’s Stock Portfolio: Top 10 Stocks to Buy and 30 Most Fantastic Stocks Every Investor Should Pay Attention To.

Disclosure: None. This article is originally published at Insider Monkey.